Project to Develop and Characterise a series of Novel Antimicrobial Agents
A funded PhD position is available in the interdisciplinary field of novel antimicrobial design and development.
The aim of the project is to optimise our new class of antimicrobial compounds through; (i) assessing their antimicrobial activity against clinically relevant bacteria; (ii) exploring the compounds toxicity towards mammalian cells and tissues; (iii) studying the localisation and interactions of these compounds towards both microbial and eukaryote cells; (iv) and working towards developing a number of key compounds that can be taken into mammalian trials.
The successful candidate will be based at the University of Kent's main campus in Canterbury, and work under the supervision of Dr Dan Mulvihill and Dr Jennifer Hiscock (University of Kent), with co-supervision by Dr Claire Peppiatt-Wildman (University of Kent) and Dr Matthew Strutt (Consultant Microbiologist). The candidate will have the unique opportunity to work with an interdisciplinary team capable of guiding this project through to Phase 1 clinical trials. They will gain experience in compound design, chemical synthesis, molecular-cell biology & live-cell imaging techniques, antimicrobial screening techniques, toxicity screening techniques and biophysical compound characterization.
This PhD Studentship is due to start in September 2017.
The studentship pays the full UK Research Council rate of £14,553 (rate for 2017/2018) plus tuition fees at the rate for UK/EU students. International applicants should make provision to meet the difference between Home/EU and international fees.